Pharmaron Beijing Co Ltd

Common Name

Pharmaron Beijing

Country

China (Mainland)

Sector

Healthcare

Industry

Biotechnology

Employees

22,908

Ticker

300759

Exchange

SHENZHEN STOCK EXCHANGE

Website

www.pharmaron.cn

Description

Pharmaron Beijing Co., Ltd. is a prominent contract research organization providing comprehensive services across the drug discovery, development, and manufacturing spectrum. Established in China's th... Show more

Financial Statements of Pharmaron Beijing

Below are the financial statements of Pharmaron Beijing, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of CNY	2024	2023
Non-current assets	—	—
Property, plant and equipment	10,944.15^a	9,851.71^a
Right-of-use assets	922.59^a	1,146.14^a
Goodwill	2,760.74^a	2,780.92^a
Other intangible assets	225.32^a	216.49^a
Investments in associates	648.98^a	722.95^a
Equity investments at fair value through profit or loss	234.06^a	282.03^a
Biological assets	175^a	157.63^a
Deferred tax assets	192.68^a	153.22^a
Other non-current assets	215.69^a	291.21^a
Total non-current assets	16,319.22^a	15,602.3^a
Current assets	—	—
Inventories	486.81^a	365.48^a
Contract costs	211.57^a	155.88^a
Trade and bills receivables	2,413.63^a	2,242.15^a
Contract assets	457.81^a	394.27^a
Biological assets	418.28^a	491.72^a
Prepayments, other receivables, and other assets	809.83^a	684.02^a
Financial assets at fair value through profit or loss	1,115.27^a	594.33^a
Derivative financial instruments	5.06^a	27.65^a
Pledged deposits	66.84^a	127.75^a
Cash and cash equivalents	1,623.07^a	5,791.17^a
Total current assets	7,608.18^a	10,874.41^a
Current liabilities	—	—
Interest-bearing bank borrowings	1,047.31^a	727.41^a
Trade payables	477.09^a	412.22^a
Other payables and accruals	1,508^a	1,377.18^a
Contract liabilities	834.86^a	740.87^a
Lease liabilities	149.51^a	185.32^a
Derivative financial instruments	47.17^a	26.93^a
Tax payable	160.08^a	184.55^a
Total current liabilities	4,224.01^a	3,654.48^a
Net current assets	3,384.17^a	7,219.94^a
Total assets less current liabilities	19,703.39^a	22,822.24^a
Non-current liabilities	—	—
Interest-bearing bank borrowings	4,377.37^a	4,308.17^a
Deferred tax liabilities	291.87^a	290.04^a
Financial liabilities at fair value through profit or loss	0^a	117.58^a
Deferred income	409.98^a	391.71^a
Convertible bonds-debt component	0^a	3,891.5^a
Lease liabilities	401.31^a	585.2^a
Total non-current liabilities	5,480.52^a	9,584.19^a
Net assets	14,222.87^a	13,238.05^a
Equity	—	—
Share capital	1,778.2^a	1,787.39^a
Treasury shares	-416.27^a	-463.45^a
Equity component of convertible bonds	0^a	198.55^a
Reserves	12,257.41^a	11,034.3^a
Equity attributable to owners of the parent	13,619.34^a	12,556.8^a
Non-controlling interests	603.54^a	681.25^a
Total equity	14,222.87^a	13,238.05^a

Verified Sources Behind Pharmaron Beijing’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Pharmaron Beijing’s data sources below and access millions more through our Disclosure Search.

a. Pharmaron Beijing's Annual Report 2024

Trace every data point back to Pharmaron Beijing’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Pharmaron Beijing Co Ltd

Financial Statements of Pharmaron Beijing

Verified Sources Behind Pharmaron Beijing’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

WuXi Biologics (Cayman) Inc

Zai Lab Ltd

Akeso Inc

Genscript Biotech Corp

Joincare Pharmaceutical Group Industry Co Ltd

Tasly Pharmaceutical Group Co Ltd